ACTRN12623000226606招募中未知
DYNAMALK: Dynamic ctDNA profiling in ALK+ Non-Small Cell Lung Cancer (NSCLC) : a study of the Australian Registry and Biobank of Thoracic Cancers (AURORA)
Peter MacCallum Cancer Centre0 个研究点目标入组 55 人开始时间: 2023年3月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Arm A: advanced ALK+ patients, treatment naïve planned to start lorlatinib
- •Arm B: advanced ALK+ patients, pre-treated at resistance to any prior ALK directed line of treatment
- •DYNAMALK is an AURORA sub-study with participation requiring enrolment in AURORA. All existing AURORA participants will be screened for DYNAMALK eligibility and offered participation. Non-AURORA patients can be enrolled into AURORA by their treating clinician specifically to participate in DYNAMALK.
排除标准
- •Diagnosis other than ALK+ NSCLC
研究者
相似试验
招募中
不适用
Implementation of up-front ctDNA analysis into lung cancer care and development of liquid biopsy-based decision support models - the Lungmarker2 studylung carcinoma10029107lung cancerNL-OMON53764Catharina-ziekenhuis800
已完成
不适用
ongkankernet implementation ctDNA Analysisnon-small cell lung cancerLung cancerNL-OMON50777Radboud Universitair Medisch Centrum250
招募中
不适用
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast CancerMetastatic Invasive Lobular Carcinoma (mILC)NCT06666439Julia Foldi20
招募中
不适用
ongitudinal characterization of circulating DNA in serum of patients after allogenic bone augmentatioPatients in need of bone augmentation prior dental implant placementDRKS00013010niversitätsklinikum Hamburg-EppendorfInstitut für Tumorbiologie35
招募中
不适用
Clinical efficacy of ctDNA dynamics before and after total neoadjuvant treatment in locally adjuvant rectal cancer.KCT0008155Chonnam National University Hospital Hwasun Hospital45